Trial intelligence / Profile preview

Rosuvastatin vs Atorvastatin in Metabolic Syndrome

NCT00395486Phase 4Completed

Sponsor
AstraZeneca
Start
Sep 2006
Primary completion
Jun 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin in hypercholesterolemia, sponsored by AstraZeneca. Started Sep 2006; status: completed.

02

Drugs

rosuvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00395486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00395486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call